Tumour cell proliferation, but not apoptosis, predicts survival in B-cell non-Hodgkin's lymphomas.

por Stokke, T., Smeland, E. B., Kvaløy, S., Holte, H.
Publicado 1998

High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells

por Blystad, AK, Holte, H, Kvaløy, S, Smeland, E, Delabie, J, Kvalheim, G
Publicado 2001

Proliferation and apoptosis in malignant and normal cells in B-cell non-Hodgkin's lymphomas.

por Stokke, T., Holte, H., Smedshammer, L., Smeland, E. B., Kaalhus, O., Steen, H. B.
Publicado 1998

Loss of chromosome 11q21–23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma

por Stokke, T, DeAngelis, P, Smedshammer, L, Galteland, E, Steen, H B, Smeland, E B, Delabie, J, Holte, H
Publicado 2001

Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer

por Fosså, A, Siebert, R, Aasheim, H-C, Mælandsmo, G M, Berner, A, Fosså, S D, Paus, E, Smeland, E B, Gaudernack, G
Publicado 2000